coated tablets with 240 mL of drinking water of ambient temperature.
Sponsors
Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence study
Bioequivalence study
EntacaponeBioequivalence study
Bioequivalence study
Rivaroxaban
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban 10 mg film-coated tablets relative to XARELTO 10 mg film-coated tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20201123001
Start: 2021-06-08Target: 30Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, fully replicate crossover design with four-period, two-treatment and two-sequence of Entacapone 200 mg film-coated tablets relative to COMTAN 200 mg film-coated tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20201207005
Start: 2021-04-22Target: 40Updated: 2026-03-30